The Mechanism of Inhibition of HIV-1 Env-Mediated Cell–Cell Fusion by Recombinant Cores of gp41 Ectodomain  by Markosyan, Ruben M. et al.
The Mechanism of Inhibition of HIV-1 Env-Mediated Cell–Cell Fusion
by Recombinant Cores of gp41 Ectodomain
Ruben M. Markosyan,* Xiuwen Ma,† Min Lu,† Fredric S. Cohen,* and Grigory B. Melikyan*,1
*Department of Molecular Biophysics and Physiology, Rush Medical College, Chicago, Illinois 60612; and †Department of Biochemistry,
Weill Medical College of Cornell University, New York, New York 10021
Received March 22, 2002; returned to author for revision May 15, 2002; accepted May 28, 2002
N36(L6)C34 is a recombinant protein that forms a six-helix bundle with high thermal stability. It consists of the N-terminal
heptad-repeat region (N36 peptide) and the C-terminal heptad-repeat region (C34) of HIV-1 gp41, connected by six polar
amino acids. The protein inhibits HIV-1 envelope-induced membrane fusion. Whether inhibition occurs while N36(L6)C34 is
in its six-helix bundle configuration was investigated. Mutating a critical residue within the N36 region to promote
dissociation of C34 from the grooves of the N36 coiled coil reduced bundle stability and increased the inhibition of fusion.
In contrast, mutating a key residue within the C34 region to reduce bundle stability decreased inhibitory potency. The data
provide strong evidence that the proteins inhibit fusion while they expose their C34 segments, rather than as six-helix
bundles. Thus, despite high thermal stability of the bundle, the recombinants’ less folded structures are present in sufficient
concentration to inhibit fusion at physiological temperatures. © 2002 Elsevier Science (USA)inhibitory peptides.
INTRODUCTION
Fusions between membranes of human immunodefi-
ciency virus type-1 (HIV-1) and a target cell are induced
by the envelope protein (Env). HIV Env is a membrane
glycoprotein assembled from three identical monomers,
with each monomer posttranslationally cleaved into two
noncovalently associated subunits—the surface subunit
gp120 and the transmembrane subunit gp41 (Wyatt and
Sodroski, 1998). Binding of gp120 to its cellular receptor
CD4 and to its coreceptor (a chemokine receptor) in-
duces conformational changes that ultimately allow gp41
to promote membrane fusion in a mechanistic way that is
as yet poorly understood (for review see Eckert and Kim,
2001).
Crystallographic analysis has shown that in the final
conformation of gp41, each of the three monomers folds
into a hairpin. The amino acid sequences of both the N-
and C-terminal portions of a hairpin exhibit heptad-re-
peats (Chambers et al., 1990; Delwart et al., 1990; Gal-
laher et al., 1989). The N-terminal portions of the hairpins
combine into a central triple-stranded coiled coil. Each of
the C-terminal helices pack into the three grooves of the
N-terminal coiled coil in an antiparallel orientation (Chan
et al., 1997; Tan et al., 1997; Weissenhorn et al., 1997).
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174This trimer of hairpins is referred to as a six-helix bundle
(Fig. 1). Several lines of evidence strongly imply that the
six-helix bundle is critically involved in membrane fusion.
First, many fusion proteins from different viral families
exhibit six-helix bundles as a final structure (Baker et al.,
1999; Caffrey et al., 1998; Kobe et al., 1999; Malashkevich,
et al., 2001; Skehel and Wiley, 1998; Zhao et al., 2000).
Second, synthetic N- and C-terminal peptides derived
from the two heptad-repeat regions of gp41 are inhibitors
of HIV infection and membrane fusion (Jiang et al., 1993;
Munoz-Barroso et al., 1998; Wild et al., 1994b). They block
fusion by competing with the corresponding heptad-re-
peat regions of gp41, thereby preventing the formation of
the six-helix bundle of gp41 (Chan and Kim, 1998; Lu et
al., 1995; Weissenhorn et al., 1997). Third, mutations that
destabilize the bundle structure of recombinant soluble
forms of gp41 (Ji et al., 1999; Lu et al., 1999) also impair
fusion when introduced into intact HIV Env (Cao et al.,
1993; Dubay et al., 1992; Weng et al., 2000; Wild et al.,
1994a).
There has been much speculation as to how the me-
chanics of six-helix bundle formation effects fusion. The
fusion peptide (a hydrophobic N-terminal segment of
gp41) is thought to insert into the target membrane prior
to fusion (White, 1992). As the bundles form, the antipa-
rallel orientation of their N- and C-terminal helical seg-
ments (Fig. 1) should bring the fusion peptides in the
target membrane and membrane-spanning domains inKey Words: membrane fusion; six-helix bundle; fusion in
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the viral envelope into close proximity. The viral envelope
and target membrane would then also be in close appo-termed
sition. The approach of the fusion peptides and mem-
brane-spanning domains toward each other (Chan and
Kim, 1998; Hughson, 1997; Weissenhorn et al., 1997) may
also directly cause the disruptions of the membranes
that are necessary for fusion (Melikyan et al., 2000;
Russell et al., 2001).
High temperatures are required to melt six-helix bun-
dles of gp41 and they are thus very stable (Lu et al.,
1995). But whether formation of a bundle is irreversible
under physiological conditions, as a practical matter,
remains unknown. Irreversibility would imply a strict se-
quence of causal events. Recombinant proteins that con-
tain the N-terminal and C-terminal heptad-repeats (re-
ferred to as N-segments and C-segments, respectively)
separated by a short, hydrophilic, six-residue linker have
been produced and shown to fold into thermally stable
six-helix bundles (Lu et al., 1999; Lu and Kim, 1997).
These recombinant core proteins thus provide models
for investigating structural and other biophysical proper-
ties of six-helix bundles. For example, does a high melt-
ing temperature (Tm) ensure that the bundle remains
stable at physiological temperatures (which are much
lower than Tm)? Also, since it is known that these recom-
binant cores inhibit HIV Env-mediated fusion (Ji et al.,
1999; Lu et al., 1999), do they inhibit as bundles or as less
folded structures in which the C- and N-segments are
exposed? If the recombinant proteins are perfectly sta-
ble, inhibition of fusion would have to be through a
mechanism different from that caused by the binding of
isolated N- and C-terminal peptides to their cognate
sites on gp41. Inhibition of fusion by the recombinant
cores has been investigated, but these prior studies
have not been able to provide the mechanism for the
inhibition nor answers to the questions posed (Ji et al.,
1999; Shu et al., 2000b). Because six-helix bundles obvi-
ously play a central role in the fusion process, determin-
ing the means by which the recombinant cores of the
bundle inhibit fusion is key. If they inhibit as six-helix
bundles, the recombinant cores could be used experi-
mentally to compete with six-helix bundles of gp41, for
example, by preventing the association of gp41 bundles
among themselves, an association that has been postu-
lated to be critical for fusion (Hughson, 1997; Weissen-
horn et al., 1997). If, in contrast, C-segments become
exposed and bind to gp41, it would mean that a high Tm
does not imply that bundle formation is irreversible.
In the present study, we devised a strategy to system-
atically investigate the mechanism by which a recombi-
nant core inhibits HIV-1 Env-mediated fusion. In separate
mutations, we altered the N-peptide and the C-peptide to
decrease the stability of the recombinant six-helix bundle
and we determined how this affected the inhibition of
fusion. Our results demonstrate that, despite a high Tm,
the recombinant bundle can reverse at physiological
conditions to expose its C-segments. The exposed seg-
ments bind to gp41 and prevent the formation of the gp41
FIG. 1. HIV-1 gp41 core structure. (A) Schematic representation of HIV-1 gp41. The important functional features of the gp41 ectodomain and the
sequences of the N36 and C34 segments are shown. The N36(L6)C34 model of the gp41 core consists of N36 and C34 plus a six-residue linker. The
disulfide bond and four potential N-glycosylation sites of gp41 are depicted. The residues are numbered according to their position in gp160 of the
HXB2 HIV-1 strain. (B) Helix packing in the gp41 core. Residues at the a and d positions of the N36 helices form the hydrophobic interface of the
trimeric coiled coil. Residues at the a and d positions of the C34 helices pack in an antiparallel orientation against residues at the e and g positions
of adjacent N36 helices.
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six-helix bundle, thereby blocking fusion by the same
mechanism as that of individual C-peptides (Chan and
Kim, 1998; Chen et al., 1995; Lu et al., 1995).
RESULTS
Rationale
N36(L6)C34 is a single-chain recombinant core protein
that consists of a 36-amino-acid stretch from the N-
terminal region (N36) linked to a 34-residue C-peptide
(C34) by six polar amino acid residues (L6). N36(L6)C34
associate to form six-helix bundles. We tested whether
the recombinant core inhibits HIV Env-mediated fusion
while it is in its six-helix bundle form or as an open
(dissociated) form. By open form, we mean a structure in
which one or more of the C34 segments are not bound
within the grooves on the surface of the N36 triple-
stranded coiled coil. We reasoned that point mutants of
N36(L6)C34 with lowered Tm, and therefore less stable
bundles, would have a higher percentage of protein in an
open form than would a wild-type recombinant protein
(Figs. 2, 3). We used mutations that were within either the
C34 or the N36 region. Both types of mutations destabi-
lize the six-helix bundle and thus favor the open struc-
ture, but mutations within N36 should lead to more po-
tent inhibition if an open structure is the inhibitory form.
This is because C-peptides are much more potent inhib-
itors than N-peptides (Lu et al., 1995, 1999; Wild et al.,
1993). In the open form, the C34 portion of the recombi-
nant protein should bind more avidly than N36 to gp41
and should therefore be responsible for preventing fu-
sion. In short, mutating the N36 segment to reduce bun-
dle stability should better expose the C34 portion and
thereby increase the recombinant protein’s inhibitory po-
tency. On the other hand, mutating C34 to destabilize the
bundle would compromise the ability of C34 to bind to
the coiled coil of gp41, and this would decrease the
potency of inhibition. If instead of blocking gp41-medi-
ated fusion as an open form the recombinant protein
blocked fusion as a six-helix bundle, the potency of
inhibition would be reduced by mutations within either
the C- or N-terminal portions.
A shorter recombinant protein, N34(L6)C28, has previ-
ously been shown to inhibit HIV-1 Env-mediated fusion.
Mutations have been made in this recombinant protein
and the inhibitory potencies compared to values of Tm (Ji
et al., 1999; Shu et al., 2000b). These studies did not lead
to a clear determination for the mechanism of inhibition
(Ji et al., 1999; Shu et al., 2000b), but they concluded that
it was unlikely that the C28 region dissociated from N34
to inhibit fusion and therefore proposed that the recom-
binant protein inhibited as a six-helix bundle (Lu et al.,
1999). In this study, we used the longer N36(L6)C34 to
test whether inhibition occurs as a bundle for two rea-
sons. First, N36(L6)C34 has a higher melting tempera-
ture and its bundle is therefore more stable than that of
N34(L6)C28. The greater stability of N36(L6)C34 allows
for mutations that would abolish bundles of N34(L6)C28
at experimentally useful temperatures. Second, the open
FIG. 2. Properties of N36(L6)C34 and its Ile 573 mutants. (A) Knobs-
into-holes packing interactions around core residue Ile 573 in the crystal
structure of the N34(L6)C28 trimer. The van der Waals surfaces identify
isoleucines at the a position. View is down the threefold axis of the trimer
from the N-terminal end. The figure was drawn with the program Turbo-
Frodo (Jones, 1978). (B) Thermal unfolding monitored by circular dichroism
at 222 nm for N36(L6)C34 (open circles), I573V (filled circles), I573A (open
squares), I573S (filled triangles), and I573P (open triangles) at a peptide
concentration of 10 M in PBS (pH 7.0). The decrease in the fraction of a
folded molecule is shown as a function of temperature. (C) Equilibrium
sedimentation data collected at 20°C and 20,000 rpm for N36(L6)C34 in
PBS (pH 7.0) at a peptide concentration of10 M. The natural logarithm
of absorbance is plotted against the square of the radius from the axis of
rotation. The data fit closely to a trimer model. Lines expected for dimeric
and tetrameric models are indicated for comparison. The deviation in the
data from the linear fit for a trimer model is plotted (upper panel). No
systematic deviation in the residuals is observed.
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structure of N36(L6)C34 can be detected more readily
than that of N34(L6)C28 because C34 is a 10- to 100-fold
more potent inhibitor of fusion than is C28 (Chan et al.,
1998; Ji et al., 1999; Lu et al., 1999; Shu et al., 2000b).
These two advantages combine to yield a much greater
range of concentrations that inhibit fusion for the larger
recombinant protein: The inhibitory concentration of the
shorter recombinant protein was less than a factor of two
greater than that of the isolated C28 peptide (Shu et al.,
2000b), whereas the inhibitory concentration of the
longer recombinant protein was more than two orders of
magnitude greater than that of C34. The much larger
dynamic range for measurement should further experi-
ments that can reveal the mechanism of inhibition.
The N36(L6)C34 mutants fold into trimeric six-helix
bundles
For mutations within N36 we focused on Ile573, gen-
erating four mutants by substituting Val, Ala, Ser, and Pro.
Residue 573 was chosen because it is at an a position of
the heptad-repeat within the interior of the N36 coiled
coil and because the hydrophobicity of the Ile side chain
is an important determinant of the thermal stability of the
six-helix bundle (Jelesarov and Lu, 2001; Lu et al., 1999).
It is also a critical residue for gp41-mediated membrane
fusion (Dubay et al., 1992). The wild-type and four mu-
tants have a large range of conformational stability, al-
lowing a determination of whether the thermal stability of
the bundle correlates with the inhibitory activity of the
recombinants.
HPLC-purified N36(L6)C34 protein and mutants were
solubilized and unfolded with 6 M guanidinium, and then
refolded by dilution into neutral pH phosphate-buffered
saline (PBS) (see Materials and Methods). On the basis
of circular dichroism (CD) measurements in PBS at 4°C,
N36(L6)C34 and the I573V, I573A, and I573S variants are
well folded, with greater than 90% -helical content (Ta-
ble 1). Sedimentation equilibrium experiments indicate
that each protein exists in a discretely trimeric state
across a concentration range from 10 to 100 M (Fig. 2C;
Table 1). The thermal stability of the recombinant core
trimers was assessed by CD, monitoring the ellipticity at
222 nm as a function of temperature. Before the unfold-
ing transition, the molar ellipticity is the same for
N36(L6)C34 (wild type, WT), I573V, I573A, and I573S and
increases linearly with temperature. The steepness of
the main transition is very similar for all four molecules,
indicating that point mutations at the 573 position do not
detectably alter the mechanism of thermal unfolding. At a
concentration of 10 M, I573V, I573A, and I573S undergo
cooperative and reversible unfolding transitions with
midpoints (Tms) of 71, 55, and 51°C, respectively, as
compared to a Tm of 76°C for the wild type at the same
concentration (Fig. 2B; Table 1). We conclude that the Val,
Ala, and Ser substitutions for Ile 573 destabilize the
six-helix bundle structure but do not affect its overall
protein fold. In contrast, the I573P variant contains80%
-helical structure and unfolds with a Tm of 40°C (Fig. 2B;
Table 1). I573P has a tendency to aggregate in solution,
as determined by sedimentation equilibrium measure-
ments. The I573P mutation essentially disrupts six-helix
bundle formation. Taken together, the CD measurements
of Tm and equilibrium centrifugation experiments show
that the WT recombinant protein and the I573V, I573A,
and I573S variants form well-structured, -helical trimers
in solution. In the present study we denatured and then
refolded the HPLC-purified WT recombinant core and
mutants. Without this added procedure, the HPLC-puri-
fied recombinant cores tend to aggregate when dis-
solved in aqueous solution (Lu et al., 1999).
TABLE 1
Biophysical Characterization of Mutant N36(L6)C34 Complexes
Peptide
[]222
a
(deg  cm2  dmol1)
Molecular
mass (kDa)
Tm
a
(°C)
IC50
(nM)
N36(L6)C34 31,500 28.1 76 217
I573V 31,700 27.5 71 39
I573A 31,300 27.5 55 8.1
I573S 31,100 27.7 51 6.9
I573P 28,900 NAb 40 2.4
I642A 31,600 27.2 71 293
I642S 31,100 26.5 67 406
a All CD scans and melts were performed at a peptide concentration
of 10 M.
b NA, not applicable. Nonrandom residuals in equilibrium analytical
ultracentrifugation data, indicative of aggregation, were observed.
FIG. 3. Thermal stability of the I642A and I642S mutants. Thermal
melts of I642A (filled circles) and I642S (open circles) monitored by
circular dichroism at 222 nm at a peptide concentration of 10 M in
PBS (pH 7.0). The decrease in the fraction of a folded molecule is
shown as a function of temperature. Inset: helical packing interactions
around residue Ile 642 in N34(L6)C28. The N34 coiled coil is repre-
sented as a molecular surface, while the C28 helix (blue) is shown as
a ribbon with selected side chains that pack into the N34 interhelical
groove. The amino termini of the N34 helices point toward the bottom
of the page and those of the C28 helices point toward the top. The
figure was prepared with the program GRASP (Nichols, 1991).
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Reducing the stability of the six-helix bundle by mutating
the N-terminal segment augments inhibitory activity
We determined the inhibitory activity of N36(L6)C34
and its mutants by fusing effector cells expressing HIV
Env to target cells expressing CD4 and CXCR4 in the
presence of varying protein concentrations. Effector and
target cells, labeled with different fluorescent cytoplas-
mic dyes, were mixed and preincubated at 23°C for an
extended period of time. Dye transfer did not occur
between cells at this nonpermissive temperature, but the
system did advance toward fusion: after creating this
temperature-arrested stage (TAS), fusion was much
faster and cells fused more synchronously when the
temperature was raised to 37°C than when cells were
immediately bound at 37°C without the extended 23°C
preincubation (Melikyan et al., 2000). After TAS was es-
tablished, recombinants were added and the tempera-
ture was then raised to 37°C for 30 min (this is a much
shorter time than would be needed for fusion if TAS had
not been established). Control experiments showed that
when 37°C was maintained for more extended times—
with or without peptides—essentially the same extents
of fusion were obtained (data not shown). Our procedure
allowed for maximal fusion for the amount of recombi-
nant core present, and the core could bind to gp41 for an
extended time after gp41 had undergone some of the
conformational changes required for its fusion.
We determined the extent of inhibition of fusion in the
presence of WT and its mutants at residue I573 (Fig. 4A).
The inhibitory potencies of all the recombinant cores
were weaker than that of synthetic C34 (in the figure
represented with crosses) and stronger than that of N36
(filled hexagons), ranging over two orders of magnitude
in concentration. There was a perfect correlation of order
between the Tm of the mutants at position 573 (Table I)
and their ability to block cell–cell fusion. This set of data
provides strong evidence that the recombinant cores
inhibit fusion while their C34 peptides are exposed (open
structure). I573S (inverted triangles) and I573P (dia-
monds) have the lowest melting temperatures, 51 and
40°C, respectively, and were almost as potent at inhib-
iting fusion as free (isolated synthetic) C34 peptide (Fig.
4A). The potencies of the recombinant cores must be
less than that of synthetic C34 if the cores inhibit fusion
as open structures, and this is borne out by the data.
(The observed recombinant cores’ greater potency of
inhibition than that of N36 is not, in principle, required of
open structure inhibition because the N36 segment is
mutated, so this result does not allow one to distinguish
between inhibition mechanisms.) Over the entire con-
centration range of N36(L6)C34, if aqueous dye transfer
was prevented, lipid dye movement was as well (data not
shown). That is, the recombinant core did not preferen-
tially inhibit fusion at low concentrations and still permit-
ted hemifusion.
We obtained IC50 (the concentration that causes 50%
inhibition of fusion) by fitting, with a Langmuir isotherm,
the data for the extent of fusion as a function of the
concentration of inhibitory recombinant cores (Fig. 4B,
shown in a linear concentration scale for the most potent
cores). The correlation between the stability of the bun-
dle and its ability to inhibit fusion is readily seen by
plotting values of IC50 vs Tm for the recombinant cores
tested (Fig. 5A). The IC50 varied roughly exponentially
with Tm with an increase of 10°C in Tm resulting in about
a fourfold increase in IC50. It may be notable that expo-
nential dependence has been found not only for the IC50
of N36(L6)C34 with Tm for mutations at position 573 of the
N-peptide: the IC50 of mutants of synthetic C34 peptides
FIG. 4. Inhibition of HIV Env-mediated cell–cell fusion by N36(L6)C34
recombinant proteins mutated within N36. (A) The extents of fusion as
a function of concentration, plotted semilogarithmically, for wild-type
recombinant and mutants at position I573, as well as synthetic N36 and
C34 peptides. The extent of fusion in the absence of recombinant
protein is defined as 100% (points not shown). Error bars are standard
errors for at least four independent measurements for each protein. (B)
Inhibition of fusion as a function of concentration shown on a linear
concentration scale for the C34 peptide and the two recombinant
proteins, I573P and I573S, with the greatest potency for inhibiting
fusion. The solid curves are Langmuir isotherms F  F0/(1C/IC50),
where F0 is the extent of fusion in the absence of inhibitor (taken as
100%) and C is the concentration of inhibitor, with IC50 set to minimize
least-square deviation. The extent of fusion should depend more
steeply on the concentration of the inhibitor than does the extent of
binding for a dominant-negative inhibition, as observed.
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in blocking fusion also varied exponentially with the Tm of
their six-helix bundles formed with synthetic N36 peptide
(Chan et al., 1998). For I573P and I573S, which have the
least stable bundles, the IC50 values—2.4 and 6.9 nM,
respectively—were close to that of free C34 peptide,
which was 2.0 nM. These small differences in IC50 indi-
cate that a substantial fraction of I573P and I573S are
open structures at 37°C, the temperature at which fusion
was induced.
We found that the ability of C34 to inhibit fusion was
readily reversed upon washing and that inhibition by the
recombinant cores was similarly reversible (data not
shown). This reversibility means that the unbound re-
combinant core maintains equilibrium with the fraction
that is bound to gp41. If fusion is inhibited by binding of
the exposed C34 segment to the coiled coil of gp41, the
concentration of open structures should be similar for all
recombinants at their IC50, all equal to the IC50 of the
isolated C34 peptide. This equality allows the fraction of
a recombinant core that is in the open structure to be
estimated as the ratio of IC50 for synthetic C34 peptide to
the IC50 of that recombinant core (Fig. 5B). The estimate
shows that about 80% of I573P and 30% of I573S are
open under physiological conditions. This fraction drops
steeply for the more stable recombinant cores, down to
only 1% for the native N36(L6)C34 at 37°C. If the rela-
tionship between IC50 and Tm could be extrapolated to
the Tm of gp41 (which we take to be 96°C) (Lu et al.,
1995), about 0.1% of gp41 would be open at 37°C.
We performed control experiments to ensure that the
inhibition by N36(L6)C34 had not been caused by a
contaminant or by a minor fraction of recombinant pro-
tein that was misfolded in some way so as to cause the
exposure of C34. We added (at 23°C) 2 M of recombi-
nant core to the solution bathing cells that had been
brought to TAS in order to bind to gp41 on the cell surface
any minor contaminant or misfolded protein that acted as
an inhibitor. We then transferred this solution to fresh
cells at TAS and again allowed the inhibitory form to
bind. This procedure was repeated one more time, the
temperature was raised to 37°C, and the extent of fusion
was measured. The degree of inhibition of fusion of the
cells exposed to recombinant core after the three rounds
of preadsorption was similar to that without the transfer
procedure. Thus, the open and closed (bundle) confor-
mations of N36(L6)C34 maintained equilibrium, and it is
unlikely that a contaminant or minor population of mis-
folded protein inhibited fusion.
Reducing bundle stability by mutating C-peptide
reduces inhibitory activity
We also destabilized the six-helix bundle of N36-
(L6)C34 by making substitutions at position I642 of its
C34 segment. The Tms of mutants I642A (71°C) and
I642S (67°C, Table I) were less than that of the wild type,
and both mutants were somewhat less effective in re-
ducing fusion than the wild-type recombinant core (Fig 6,
Table 1). The difference in inhibitory efficacy was great-
est, and clearly significant, at recombinant protein con-
centrations of 1 M (Fig. 6). In contrast to the muta-
tions of I573 within N36, for mutations of I642 within C34
the values of IC50 varied inversely with Tm (Fig. 6, inset).
The mutations of residue I642 promote the opening of
the bundle, but the mutated C34 is less able to block
fusion than the wild-type sequence. Notably, mutation of
the C34 segment has a greater effect on reducing bind-
ing to gp41 than on promoting bundle opening. That C34
binding causes the inhibition of fusion is underscored by
FIG. 5. Dependence of fusion inhibitory potencies and the fraction of
open structures as a function of thermal unfolding temperatures (Tm) for
N36(L6)C34 recombinant proteins mutated at position I573. (A) The IC50
values for the recombinant proteins obtained from the plots of Fig. 4 are
plotted against their melting temperatures. The solid line is an expo-
nential fit for the dependence of IC50 on Tm; the dotted line shows the
IC50 for the synthetic C34 peptide. (B) The fraction of recombinant
protein in an open form (a C34 segment is exposed), calculated as the
ratio of IC50 for free C34 to that of the recombinant protein, at 37°C as
a function of Tm. This calculation assumes that only one of the three
possible exposed C34 segments per trimer of recombinant core inhib-
its fusion. Alternatively, the open structure could expose three C34
segments and each segment could inhibit independently of the other
two. The percentage of a recombinant core in an open structure would
then be one-third of our estimate. Our estimate should be the maximum
percentage of trimeric recombinant cores that are in open structures.
We consider it likely that only one exposed C34 segment of each
recombinant core can inhibit fusion because binding of one segment
should constrain the possible orientations of the other two; the linker
between the N36 and C34 segments is relatively short, being only six
amino acid residues in length.
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the 10-fold lower value of IC50 for I573V than for I642A,
even though both mutants have roughly the same Tm.
The inhibitory activity of the open structure is thus pri-
marily conferred by the exposed C34 segment; exposed
N36 is of significantly less consequence.
DISCUSSION
Small amounts of open forms can inhibit fusion
Our data yield straightforward evidence that N36(L6)-
C34 blocks gp41-mediated fusion as an open structure
with its C34 segment exposed. The high thermal stability
(i.e., the high Tm) of the six-helix bundle might imply that
its dissociation into an open form would be so negligible
at physiological temperatures that the observed inhibi-
tion must be caused by the recombinant six-helix bundle.
However, this is fallacious for several reasons. First,
values of Tm are typically quoted for higher concentra-
tions (10 M) of recombinant proteins than are needed
(well below 1 M) to block fusion in our system (Fig. 4).
The value of Tm decreases with decreasing concentra-
tion of recombinant proteins (Jelesarov and Lu, 2001).
Second, C-peptides inhibit fusion through a dominant-
negative mechanism (Chan and Kim, 1998; Lu et al., 1995;
Weissenhorn et al., 1997). Because more than one copy
of Env is undoubtedly required to generate a fusion pore,
fusion will depend steeply on the density of functional
Env. As a consequence, small amounts of open struc-
tures of the recombinants can block fusion. Functional
assays for fusion can detect the presence of these open
structures, whereas biochemical detection is difficult. We
estimate that somewhat less than 0.1% of the recombi-
nant in an open form can be detected by inhibition of
fusion.
Mutations in the C34 segment result in competing
effects: destabilization of the bundle (which decreases
IC50) and reduction of the inhibitory efficacy of the ex-
posed C34 segment. IC50 increased as Tm was reduced
for mutations at position 642 of the C-peptide (Fig. 6,
inset), showing that the reduced efficacy of the exposed
C34 segment in blocking fusion is the more consequen-
tial effect. These competing effects result in an increase
(twofold) in IC50 for a mutation in the C34 segment
smaller than the decrease (fourfold) in IC50 for a mutation
at position 573 of the N36 segment (for every 10°C
decrease in Tm caused by mutation). The larger quanti-
tative effect for mutations in the N-peptide region is
expected because the only effect of mutations in the N36
segment is to destabilize the bundle. It was found in a
prior study that for every decrease in Tm of 10°C for
mutations within the C34 peptide (corresponding to po-
sition 631), IC50 increased sevenfold (Chan et al., 1998).
This increase in IC50 greater than that caused by muta-
tions within the C34 segment of the recombinant core is
expected because a mutation within the C34 segment
that promotes open structures must also reduce the
binding affinity of the exposed segments to the grooves
of the coiled coil of gp41.
If a single C-segment were to dissociate from the
coiled coil, the vacated groove on the coiled coil could, in
principle, inhibit fusion if it then bound C-terminal seg-
ments of gp41. A five-helix peptide consisting of three
N-peptides and two C-peptides arranged in a single
chain has, in fact, recently been found to inhibit fusion
(Root et al., 2001). The N-peptides fold into a coiled coil
and the presence of only two C-peptides results in one
vacant groove on the coiled coil. Since C34 is about
20-fold more potent than this five-helix peptide, C34 that
has dissociated from the bundle of N36(L6)C34, rather
than the presence of vacant grooves, should be the
major contributor to the inhibition of fusion.
Correlation between the stability of the six-helix
bundle and its inhibitory activity for N34(L6)C28
Prior studies, using the shorter N34(L6)C28 and mu-
tants, yielded data that were not fully consistent with the
recombinant protein inhibiting fusion as either a six-helix
bundle or as an open structure (Ji et al., 1999; Shu et al.,
2000b). In reviewing all of the prior data, we are now able
to analyze and interpret much of it in accord with our
proposed mechanism. In the cases of those mutants of
N34(L6)C28 whose data we could not reconcile with our
interpretation, we conducted new fusion experiments
ourselves (Fig. 7B). With these new experiments, we can
now provide a cohesive view of fusion inhibition.
We made a plot of the data from previous studies for
inhibition of fusion by N34(L6)C28 and its mutants (Ji et
al., 1999; Shu et al., 2000b) and it shows that IC50 and Tm
did not correlate (Fig. 7A). However, we can see from our
FIG. 6. Inhibition of fusion as a function of concentration for recom-
binant proteins mutated at position I642 within C34. I642A (filled
squares), I642S (filled inverted triangles), and wild-type N36(L6)C34
(open circles) are shown. Inset: IC50, determined by fitting data points
with a Langmuir binding isotherm (see the legend to Fig. 4), as a
function of Tm for the recombinant proteins.
180 MARKOSYAN ET AL.
plot that a correlation can be made for the mutants with
values of Tm greater than the temperature used to induce
fusion (37°C), with the exception of Q652L (a mutation in
the C28 segment; Fig. 7A, open triangle). The Q652L
anomaly can be explained, however, by the greater po-
tency of the mutated C28 segment when it is exposed:
when Q652 was substituted by L652 in synthetic C28, the
IC50 decreased by about a factor of four (Shu et al.,
2000b). For the mutants with Tm  25°C (Fig. 7A, points
within box), the absence of a correlation is not surprising;
most of the recombinant proteins would be unfolded and
this would tend to lead to aggregation. Aggregation,
made more likely by the high concentrations used in the
prior studies (see legend to Fig. 7), would render them
less active. The recombinant mutant proteins that do
correlate all have relatively high values of Tm (50°C).
However, for these mutants the recombinant proteins are
more potent inhibitors of fusion, on a mole basis, than
isolated C28 peptide, and this result cannot be explained
by either of the two mechanisms. On the one hand, the
correlation is the reverse of what should occur if the
recombinant protein inhibits as a bundle; on the other
hand, recombinant proteins cannot inhibit fusion with a
potency greater than that of isolated C-peptides if the
exposed C-segments of open structures are the inhibit-
ing agent (assuming that only one C-peptide per open
structure can inhibit).
Because these previous studies led to inconsisten-
cies, we measured, in our system, the inhibitory poten-
cies of the anomalously effective recombinant proteins
W571R and L568A/W571R as well as Q652L and C28. We
found that the order of potencies still correlated as in the
previous studies, but that C28 inhibited fusion more
effectively than any of these recombinants, except for
L568A/W571R (Fig. 7B, open circle, experimental). This
may indicate that L568A/W571R dissociates into mono-
mers and that its open structure is three monomers
rather than a trimer. If this double mutant (having both
mutations within the coiled coil) with a relatively low Tm
were to completely dissociate into monomers and
thereby expose all three of its C28 segments, the effec-
tive concentration of the inhibitory segments would be
three times that of the recombinant protein concentra-
tion. If it did dissociate into three monomers, inhibition by
this mutant (Fig. 7B, filled circle) would be less effective,
on a mole basis, than that of C28. Thus, a critical analysis
of the data favors the conclusion that N34(L6)C28 inhibits
fusion in an open form because the correlation for mu-
tations within N34 (that do not lower Tm to an extent that
would cause recombinant aggregation) shows that the
more likely it is for C28 to become exposed, the better it
is as an inhibitor. The anomalous potency of the Q652L
mutant actually strengthens this conclusion by showing
that the more potent the inhibition by free C-peptide, the
greater the inhibition by the recombinant protein. More-
over, all of the data lead to the conclusion that equilib-
rium is maintained between bundles and open struc-
tures.
Implications for gp41-mediated fusion
The high thermal stability (Tm  90°C) of the six-helix
bundle formed by a water-soluble fragment of the gp41
ectodomain (Lu et al., 1995; Weissenhorn et al., 1996)
indicates that (on the time scale of the Env-mediated
FIG. 7. (A) The dependence of IC50 on Tm for the recombinant
N34(L6)C28 mutants (data from Ji et al., 1999; Shu et al., 2000). The
recombinant protein with the mutation Q652L in C28 stabilizes the
bundle (open triangle). The three mutants with the lowest values of Tm
(all containing the mutation I573S) are enclosed in a square. (The Tm for
the triple mutant L568A/W571R/I573S was measured to be20°C (Ji et
al., 1999); the arbitrary value of 15°C was assigned to this plot.) For the
other mutants, connected by the solid line, IC50 and Tm correlated.
However, some of the mutant recombinant proteins that exhibit the
expected correlation were measured to be more potent inhibitors of
fusion than C28, which would run counter to inhibition as an open
structure. (B) Several of the anomalously potent N34(L6)C28 mutants
were retested and exhibited the same order of potency for the stable
cell lines as that previously reported for the infected cells. However, in
contrast to the previous reports, W571R was less potent at inhibiting
fusion than C28. The double mutant L568A/W571R (experimental) was
still somewhat more potent. In the extreme case of dissociation into
monomers, it would be a less potent inhibitor than C28. Note that the
N34(L6)C28 recombinant proteins and the isolated peptides were more
than 10-fold less effective in blocking fusion in the previous studies
than found with our cells. The differences in concentration are probably
due to the use of HIV-infected cells in the prior studies (Ji et al., 1999;
Shu et al., 2000b) as opposed to the stably transfected cells in our
study. Because acutely infected cells should express higher levels of
Env than stably transfected cells, fusion should be more difficult to
inhibit with infected cells.
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fusion process) once bundles form, the fraction that dis-
sociates is negligible. But it has been argued that six-
helix bundles of proteins that model the core of gp41
readily dissociate into monomers when they interact with
membranes, despite the stability in solution (Kliger et al.,
2000). This claim contrasts with the finding that the
bundle of N34(L6)C28 resists dissociation by detergent
and by liposomes (Shu et al., 2000a). Also, antibodies
that specifically recognize the six-helix bundle structure
have increased binding after the addition of soluble CD4
to HIV Env-expressing cells (de Rosny et al., 2001; Jiang
et al., 1998). This finding indicates that the gp41 bundle
did not dissociate within the lipid bilayer. (Soluble CD4
caused shedding of gp120 from gp41 for the cells used in
those studies, and therefore the gp41 folded into a bun-
dle via an inactivation pathway.)
Whether formation of a bundle by gp41 is irreversible
is of great importance for understanding the mechanism
of viral fusion. Any stabilization of the bundle by struc-
tural features of a trimer, such as the disulfide-bonded
loop between the N- and C-heptad repeats, should be
reflected in the measured Tm of the ectodomain of gp41.
Factors that would not contribute to the melting temper-
ature but that could stabilize the bundle would include
the reduced degrees of freedom for a protein anchored
to membranes (through its membrane-spanning domain
in the viral membrane and through insertion of the fusion
peptides into the target membrane) (Chan and Kim, 1998;
Melikyan et al., 2000; Weissenhorn et al., 1997).
Fusion proteins concentrate during the fusion process
sufficiently to be chemically cross-linked (Markovic et al.,
1998), but it is not known whether there are specific
protein–protein interactions between them. N36(L6)C34
does not inhibit fusion as a six-helix bundle, even though
the overwhelming majority of the recombinant protein
has this structure at 37°C. Whatever the function of a
six-helix bundle of gp41, it is unlikely that the bundle is
required to interact with another bundle or with other
portions of proteins, since the added recombinant bun-
dles did not inhibit fusion. We thus conclude that if
multiple copies of gp41 associate during the fusion pro-
cess, they do so through interactions between regions of
the protein that do not include the six-helix bundle.
MATERIALS AND METHODS
Recombinant protein production and purification
Mutations were introduced into the recombinant
N36(L6)C34 core protein that models the gp41 ectodo-
main (Lu and Kim, 1997) using the method of Kunkel
(1987) and verified by DNA sequencing. N36(L6)C34 con-
sists of residues 546–581 (N36) and 628–661 (C34) of Env
joined by a linker of six hydrophilic residues. All
N36(L6)C34 variants were recombinantly expressed in
Escherichia coli strain BL21(DE3)/pLysS (Novagen, Mad-
ison, WI). Cells were grown at 37°C in LB medium to an
optical density of 0.8 at 600 nm and induced with isopro-
pyl -D-thiogalactoside for 3 to 4 h. Cells were lysed at
0°C by glacial acetic acid. The bacterial lysate was
centrifuged (35,000 g for 30 min) to separate the soluble
fraction from inclusion bodies. The soluble fraction, con-
taining denatured recombinant protein, was dialyzed into
5% acetic acid overnight at room temperature. Recombi-
nant proteins were purified from the soluble fraction to
homogeneity by reverse-phase HPLC (Waters, Inc., Mil-
ford, MA) on a Vydac C-18 preparative column, using a
water–acetonitrile gradient in the presence of 0.1% triflu-
oroacetic acid, and lyophilized. Purified proteins were
solubilized in 6 M guanidinium hydrochloride (and 50
mM sodium phosphate (pH 7.0) and refolded by dilution
into neutral pH PBS. The N36 and C34 peptides were
synthesized by solid-phase fluorenylmethoxycarbonyl
peptide chemistry and had an acetylated amino terminus
and an amidated carboxyl terminus. After cleavage from
the resin, peptides were desalted with a Sephadex G-25
column (Amersham, Pharmacia Biotech, Piscataway, NJ)
and purified by HPLC as described above. Peptide iden-
tities were confirmed by matrix-assisted laser-desorption
ionization mass spectrometry (Voyager Elite, PerSeptive
Biosystems, Cambridge, MA). Peptide concentrations
were measured by absorbance at 280 nm in 6 M guani-
dinium hydrochloride (Edelhoch, 1967). Stock solutions
of 200–600 M of the peptides in water were prepared,
frozen in aliquots, and stored at –20°C. Control experi-
ments demonstrated that the inhibitory activity of these
peptides was not affected by freezing.
Circular dichroism spectroscopy
CD experiments were performed on an Aviv 62A DS
circular dichroism spectrometer. The wavelength depen-
dence of molar ellipticity, [], was monitored at 4°C for a
10 M protein solution in 50 mM sodium phosphate, pH
7.0, and 150 mM NaCl (PBS). Helix content was calcu-
lated as described (Chen et al., 1974). Thermal stability
was determined by monitoring the change in []222 as a
function of temperature. Thermal melts were performed
in 2°C increments with an equilibration time of 120 s at
the desired temperature and an integration time of 30 s.
All melts were reversible. Superimposable folding and
unfolding curves were observed, and 85% of the signal
was regained upon cooling. The midpoint of the thermal
unfolding transition (Tm) was determined from the maxi-
mum of the first derivative, with respect to the reciprocal
of the temperature, of the []222 values (Cantor, 1980). The
error in estimation of Tm is 0.5°C.
Sedimentation equilibrium
Sedimentation equilibrium experiments were per-
formed on a Beckman XL-A analytical ultracentrifuge
(Beckman Instruments, Fullerton, CA) using an An-60 Ti
rotor. Protein solutions were dialyzed overnight against
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PBS (pH 7.0), loaded at initial concentrations of 10, 30,
and 100 M, and analyzed at rotor speeds of 20,000 and
23,000 rpm at 20°C. Data sets were fitted simultaneously
to a single-species model of ln(absorbance) versus (rad-
ical distances)2 using the program NONLIN (Johnson et
al., 1981). Protein partial specific volume and solvent
density were calculated as described (Laue et al., 1992).
The molecular weights of N36(L6)C34 and its variants,
except for I573P, were all within 10% of those calculated
for an ideal trimer, with no systematic deviation of the
residuals.
Cell maintenance
Cells stably expressing HIV-1 Env from BH10 strain
(TF228.1.16) were obtained from Dr. Zdenka Jonak (Smith-
Kline Beecham, Philadelphia, PA) and grown in suspen-
sion in RPMI 1640 supplemented with 10% Cosmic Calf
serum (HyClone Laboratories, Logan, UT). The target
cells (HeLaT4) expressing CD4 and CXCR4 (Maddon et
al., 1986) were obtained from the NIH Research and
Reference Reagent Program. HeLaT4 cells were main-
tained in DMEM supplemented with 10% Cosmic Calf
serum and 0.5 mg/ml of G418 sulfate (Mediatech Inc.,
Herndon, VA).
Cell labeling and cell–cell fusion assay
About 7  106 effector TF228.1.16 cells were labeled with
2.5 M of cytoplasmic dye calceinAM, and slightly sub-
confluent target HeLaT4 cells on 6-cm dishes (4 
106 cells) were labeled with 80 M of CellTracker Blue,
CMAC (both dyes were from Molecular Probes, Eugene,
OR), as described (Melikyan et al., 2000). The target and
effector cells were mixed at a 1:1 ratio, resuspended in
HEPES-buffered DMEM (GIBCO BRL, Gaithersburg, MD)
supplemented with 0.1% BSA (Sigma Chemical Co., St.
Louis, MO) at 106 cells/ml, and immediately transferred
into a polylysine-coated eight-chambered slide (Lab-Tek,
Nalge Nunc International, Naperville, IL). The effector
and target cells adhered to the polylysine and randomly
established contacts with each other. The chosen cell
density favored contacts and fusion between cell pairs.
The effector and target cells were coincubated for 2.5 h
at 23°C, after which time different concentrations of
inhibitory recombinant proteins and peptides dissolved
in DMEM–0.1%BSA solution were added to the wells.
Proteins and peptides were allowed to bind for 30 min at
23°C, followed by incubation at 37°C for 30 min. As a
result of fusion, cells became stained with both cal-
ceinAM (green emission) and CMAC (blue emission).
Fusion was quantified under a Leitz Laborlux D fluores-
cent microscope by calculating the fraction of effector–
target cell contacts that had fused in each field, as
described (Melikyan et al., 2000). About 100 cell pairs
were screened per well and at least four independent
experiments in duplicates were carried out to determine
the extent of fusion for a given peptide concentration.
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